Details for New Drug Application (NDA): 017322
✉ Email this page to a colleague
NDA 017322 describes SELENOMETHIONINE SE 75, which is a drug marketed by Ge Healthcare, Mallinckrodt, and Pharmalucence, and is included in three NDAs. Additional details are available on the SELENOMETHIONINE SE 75 profile page.
The generic ingredient in SELENOMETHIONINE SE 75 is selenomethionine se-75. There is one drug master file entry for this compound. Additional details are available on the selenomethionine se-75 profile page.
The generic ingredient in SELENOMETHIONINE SE 75 is selenomethionine se-75. There is one drug master file entry for this compound. Additional details are available on the selenomethionine se-75 profile page.
Summary for 017322
| Tradename: | SELENOMETHIONINE SE 75 |
| Applicant: | Pharmalucence |
| Ingredient: | selenomethionine se-75 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 500uCi/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
